| MyFox Houston |
style = class = “lh”> Amylin Pharmaceuticals won federal approval Friday for its new, more convenient drug for type 2 diabetes and ends years of setbacks. The drug, Bydureon is injected once a week. Its main competitor is expected to Novo Nordisk’s Victoza, … Drug diabetes injection wins FDA approval for two previous … size =
|